Successful treatment of natural killer (NK) cell leukemia following a long-standing chronic active Epstein-Barr virus (CAEBV) infection with allogeneic bone marrow transplantation.

Ebihara, Y; Manabe, A; Tanaka, R; Yoshimasu, T; Ishikawa, K; Iseki, T; Hayakawa, J; Maeda, M; Asano, S; Tsuji, K

Ebihara, Y; Manabe, A; Tanaka, R; Yoshimasu, T; Ishikawa, K; Iseki, T; Hayakawa, J; Maeda, M; Asano, S; Tsuji, K.

Affiliation

Ebihara Y; Department of Pediatric Hematology/Oncology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.

Bone Marrow Transplant ; 31(12): 1169-71, 2003 Jun.

Article in En | MEDLINE | ID: mdl-12796798

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Leukemia, Lymphoid / Bone Marrow Transplantation / Epstein-Barr Virus Infections Limits: Adolescent / Humans / Male Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2003 Document type: Article Affiliation country: Japón Country of publication: Reino Unido

Search on Google

Add to My VHL

XML

PubMed Links